Journal Article

Fatal 4-MTA Intoxication: Development of a Liquid Chromatographic-Tandem Mass Spectrometric Assay for Multiple Matrices

T. Decaestecker, E. De Letter, K. Clauwaert, M.P. Bouche, W. Lambert, J. Van Bocxlaer, M. Piette, E. Van den Eeckhout, C. Van Peteghem and A. De Leenheer

in Journal of Analytical Toxicology

Volume 25, issue 8, pages 705-710
Published in print November 2001 | ISSN: 0146-4760
Published online November 2001 | e-ISSN: 1945-2403 | DOI: http://dx.doi.org/10.1093/jat/25.8.705
Fatal 4-MTA Intoxication: Development of a Liquid Chromatographic-Tandem Mass Spectrometric Assay for Multiple Matrices

More Like This

Show all results sharing these subjects:

  • Medical Toxicology
  • Toxicology (Non-medical)

GO

Show Summary Details

Preview

The case history and toxicological findings of an overdose fatality involving 4-methylthioamphetamine (4-MTA) and 3,4-methylenedioxymethamphetamine (MDMA) are reported along with a description of the analytical method. Detection and quantitation of 4-MTA and MDMA were performed by liquid chromatography—tandem mass spectrometry using phentermine as internal standard. Application of this technique to a variety of matrices allowed an insight in the distribution of 4-MTA. Several blood samples including femoral vein blood (5.23 mg/L), urine (95.5 mg/L), vitreous humor (1.31 mg/L), bile (36.4 mg/L), and numerous tissue samples such as liver (30.8 mg/kg), spleen (4.10 mg/kg), and frontal lobe (31.7 mg/kg) were assayed. These values indicated that 4-MTA could be identified as the cause of this fatality, whereas the concentrations of MDMA, also described, are less important because the concentrations found are lower. This case reports, for the first time, an extensive toxicological analysis of 4-MTA, by which the data presented may shed some light on the distribution of 4-MTA.

Journal Article.  0 words. 

Subjects: Medical Toxicology ; Toxicology (Non-medical)

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.